ArticlePloS one2018

Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc.

Kathleen Listiak Vincent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.